Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Board Changes

15 Jun 2022 11:06

RNS Number : 9787O
JLEN Environmental Assets Group Ltd
15 June 2022
 

15 June 2022

JLEN Environmental Assets Group Limited

 

Board Changes

 

The Board of JLEN Environmental Assets Group Limited ("JLEN" or the "Company") announces that Richard Morse has confirmed his intention to step down as non-Executive Chair of the Company, effective 15 July 2022, having served as a Director of the Company for nearly nine years.

 

The recruitment process for Richard's successor as Chair is in advanced stages and the Directors look forward to announcing the conclusion shortly. The Board would like to thank Richard for his commitment and dedication to the Company since its launch, and to wish him every success for the future.

 

Richard Ramsay, Senior Independent Director, said:

 

"We are grateful to Richard for his time and effort whilst on the Board of JLEN. As one of the Company's founding Directors, Richard has been instrumental in shaping the Board and driving effective governance through his collegiate and thoughtful leadership."

 

 

For further information please contact:

 

Foresight Group

Chris Tanner

Chris Holmes

 

+44(0)20 3667 8100

Winterflood Investment Trusts 

Neil Langford

Chris Mills

+44(0)20 3100 0000

 

SEC Newgate

Elisabeth Cowell

 

+44(0)20 3757 6882

 

Sanne Fund Services 

Matt Falla

Gemma Woods 

+44(0)1481 755530

 

About JLEN

JLEN's investment policy is to invest in a diversified portfolio of Environmental Infrastructure. Environmental Infrastructure is defined by the Company as infrastructure assets, projects and asset-backed businesses that utilise natural or waste resources or support more environmentally friendly approaches to economic activity, support the transition to a low carbon economy or which mitigate the effects of climate change. Such investments will typically feature one or more of the following characteristics:

 

· long-term, predictable cash flows, which may be wholly or partially inflation-linked cash flows;

· long-term contracts or stable and well-proven regulatory and legal frameworks; or

· well-established technologies, and demonstrable operational performance

 

JLEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly and to preserve the capital value of the portfolio over the long term on a real basis. The target dividend for the year to 31 March 2023 is 7.14 pence per share1. The dividend is payable quarterly.

 

Further details of the Company can be found on its website www.jlen.com

 

LEI: 213800JWJN54TFBMBI68

 

(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKPBKKBKDNAD
Date   Source Headline
1st May 20197:00 amRNSNotice of Results
15th Mar 201910:37 amRNSUpdate research from QuotedData
13th Mar 20194:56 pmRNSJohn Laing Pension Trust - Result of Share Sale
8th Mar 20197:00 amRNSJohn Laing Pension Trust - Proposed Sale of Shares
7th Mar 20197:00 amRNSNet Asset Value and Dividend
19th Dec 20187:00 amRNSAcquisition
30th Nov 20184:19 pmRNSTotal Voting Rights
22nd Nov 20187:00 amRNSHalf-year Results, Dividend Declaration
9th Nov 20187:00 amRNSNotice of Results
24th Oct 20185:11 pmRNSDirector/PDMR Shareholding
24th Oct 20183:59 pmRNSHolding(s) in Company
24th Oct 20183:47 pmRNSHolding(s) in Company
19th Oct 201811:55 amRNSResult of Issue
13th Sep 201811:44 amRNSUpdate research from QuotedData
12th Sep 20187:00 amRNSProposed Placing, Offer for Subscription
3rd Sep 20185:59 pmRNSHolding(s) in Company
23rd Aug 20181:04 pmRNSHolding(s) in Company
16th Aug 20187:01 amRNSNet Asset Value and Dividend Declaration
16th Aug 20187:00 amRNSAcquisition
15th Aug 20183:58 pmRNSResult of AGM
9th Jul 20187:00 amRNSAcquisition
26th Jun 201811:56 amRNSNotice of AGM
22nd Jun 20182:59 pmRNSPublication of Suppl.Prospcts
22nd Jun 20188:15 amRNSAcquisition
14th Jun 20187:00 amRNSAnnual Financial Report
31st May 20187:00 amRNSNet Asset Value and Dividend Declaration
23rd May 20187:00 amRNSCapital Markets Event
13th Apr 20184:29 pmRNSDirector Declaration
29th Mar 20185:48 pmRNSTotal Voting Rights
14th Mar 20185:57 pmRNSHolding(s) in Company
7th Mar 20187:00 amRNSResult of Initial Placing
6th Mar 20181:32 pmRNSUpdate research from QuotedData
2nd Mar 201811:09 amRNSResult of EGM
23rd Feb 201812:11 pmRNSPublication of Prospectus
21st Feb 20188:18 amRNSProposed Initial Placing
12th Feb 20187:00 amRNSPublication of Circular & Notice of EGM
2nd Feb 20187:00 amRNSAcquisition
23rd Jan 20187:00 amRNSNet Asset Value and Dividend Declaration
12th Dec 20177:00 amRNSAcquisition
6th Dec 201711:50 amRNSHolding(s) in Company
22nd Nov 20177:00 amRNSHalf-year Results, Dividend Declaration
6th Nov 20177:00 amRNSInvestment Adviser
8th Sep 20177:55 amRNSInitiation research from QuotedData
29th Aug 20177:00 amRNSAcquisition
17th Aug 20177:00 amRNSNet Asset Value and Dividend
16th Aug 20171:11 pmRNSResults of AGM
31st Jul 20177:00 amRNSTotal Voting Rights
14th Jul 20179:52 amRNSHolding(s) in Company
13th Jul 20173:16 pmRNSHolding(s) in Company
12th Jul 201710:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.